The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem

Zacks12-05

For Immediate Release Chicago, IL – December 5, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2489323874?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qdU1PXE.HrZUiwGNwSpI8Q--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6d46ed8fcc6d04a0d687ddd317d1fb0b","is_english":true,"pubTime":"2024-12-05 18:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2489323874","market":"us","top_or_hot":-1,"title":"The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem","media":"Zacks","content":"<div>\n<p>For Immediate Release\nChicago, IL – December 5, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...</p>\n\n<a href=\"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-amgen-100000092.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-05 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/zacks-analyst-blog-highlights-amgen-100000092.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For Immediate Release\nChicago, IL – December 5, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...</p>\n\n<a href=\"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-amgen-100000092.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-amgen-100000092.html","article_id":"2489323874","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qdU1PXE.HrZUiwGNwSpI8Q--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6d46ed8fcc6d04a0d687ddd317d1fb0b"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489323874","pubTimestamp":1733392800,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Chicago, IL – December 5, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amgen Inc. AMGN, Eaton Corp. plc ETN, Sony Group Corp. SONY, iMage Technologies, Inc. MITQ and Enzo Biochem, Inc. ENZ.Here are highlights from Wednesday’s Analyst Blog:. Top Stock Reports for Amgen, Eaton and Enzo Biochem. However, Evenity, Repatha, Prolia, Tavneos and Tezspire, are driving sales exponentially. The addition of Horizon products boosted revenue growth in the first half of the year. Amgen also has some key pipeline assets in obesity and inflammation, which have a large market opportunity.However, Sony’s performance is affected by reduced hardware sales, forex volatility and intense competition across major product categories. Continued slowdown across the financial services business and lower series","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2242646821.SGD":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2463526074.USD":"NORDEA 1 - GLOBAL CLIMATE ENGAGEMENT \"BP\" (USD) ACC","BK4566":"资本集团","IE00B3CCJ633.GBP":"GUINNESS SUSTAINABLE ENERGY \"C\" (GBP) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4196":"保健护理服务","IE00B2PGVK34.USD":"GUINNESS SUSTAINABLE ENERGY \"C\" (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0061474960.USD":"天利环球焦点基金AU Acc","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","ENZ":"恩佐生化","IE00BGHQF417.EUR":"GUINNESS SUSTAINABLE ENERGY \"C\" (EUR) ACC","BK4577":"网络游戏","BK4588":"碎股","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","BK4571":"数字音乐概念","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","MITQ":"Moving iMage Technologies Inc.","LU1861214812.USD":"Blackrock Future of Transport A2 USD","ETN":"伊顿","LU1861219969.SGD":"Blackrock Future of Transport A2 SGD-H","BK4581":"高盛持仓","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BK4096":"电气部件与设备","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH  \"AG\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","SONY":"索尼","LU0096362180.USD":"CT (LUX) I GLOBAL FOCUS \"DU\" (USD)","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","LU0058720904.USD":"联博国际健康护理基金A","IP":"国际纸业","BK4585":"ETF&股票定投概念","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","BK4539":"次新股","BK4554":"元宇宙及AR概念","BK4599":"减肥药","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4108":"电影和娱乐","AMGN":"安进"},"translate_title":"Zacks分析师博客重点介绍了安进、伊顿、索尼、iMage和Enzo Biochem","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IP":1,"SONY":1,"MITQ":1,"AMGN":1,"ETN":1,"ENZ":1},"content_text":"For Immediate Release\nChicago, IL – December 5, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Amgen Inc. AMGN, Eaton Corp. plc ETN, Sony Group Corp. SONY, iMage Technologies, Inc. MITQ and Enzo Biochem, Inc. ENZ.\nHere are highlights from Wednesday’s Analyst Blog:\nTop Stock Reports for Amgen, Eaton and Enzo Biochem\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc., Eaton Corp. plc and Sony Group Corp., as well as two micro-cap stocks, Moving iMage Technologies, Inc. and Enzo Biochem. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.\nYou can see all of today’s research reports here >>>\nAmgen’s shares have underperformed the Zacks Medical – Biomedical and Genetics industry over the last six months (-9.4% vs. -2.0%). The Zacks analyst believes that increased pricing headwinds and competitive pressure are hurting sales of many products, including some biosimilars. Weakness in some key brands like Otezla and Lumakras pose potential threat.\nHowever, Evenity, Repatha, Prolia, Tavneos and Tezspire, are driving sales exponentially. The addition of Horizon products boosted revenue growth in the first half of the year. Amgen also has some key pipeline assets in obesity and inflammation, which have a large market opportunity.\n(You can read the full research report on Amgen here >>>)\nEaton’s shares have outperformed the Zacks Manufacturing - Electronics industry over the past year (+65.7% vs. +33.9%). The Zacks analyst believes that the company benefits from research and development work and is aided by rising demand from the new AI data center. Eaton is expanding via acquisitions and strategy to manufacture in the region of its end market has helped the company to reduce expenses.\nYet, Eaton’s global operations expose it to unpredictable currency translation, cyber security threats, changes in tax rates and security breaches, which might impact operations. The shortage of raw materials and supplier insolvencies might impact production and operations.\n(You can read the full research report on Eaton here >>>)\nShares of Sony have outperformed the Zacks Audio Video Production industry over the past year (+18.4% vs. +13.0%). Per the Zacks analyst, steady growth across the G&NS, Music and I&SS segments has been a tailwind for Sony. The G&NS unit is gaining from favorable forex impact, higher sales from network services (PlayStation Plus) and rising sales of non-first-party titles.\nHowever, Sony’s performance is affected by reduced hardware sales, forex volatility and intense competition across major product categories. Continued slowdown across the financial services business and lower series deliveries in Television Productions have also ailed.\n(You can read the full research report on Sony here >>>)\nMoving iMage’s shares have underperformed the Zacks Technology Services industry over the last six months (-35.5% vs. +43.7%). The Zacks analyst believes that supply chain disruptions, competition from OTT platforms and regulatory compliance costs have continued to ail the company. Hollywood strikes earlier this year impacted demand for its products.\nYet, its significant contract win with Alamo Drafthouse Cinema and expansion into high-margin SaaS and subscription-based products like MiTranslator and CineQC show great promise. Also, diversifying into live entertainment and eSports markets mitigates cinema industry cyclicality.\n(You can read the full research report on Moving iMage here >>>)\nEnzo’s shares have underperformed the Zacks Medical – Biomedical and Genetics industry over the past year (-13.7% vs. +1.0%). The Zacks analyst believes that persistent net losses, high operating costs, the exit from clinical labs reducing revenue streams and competitive pressures pose risks for the company. Addressing legal expenses are also crucial for sustained profitability.\nYet, Enzo’s strategic pivot toward becoming a dedicated life sciences tools manufacturer has been effectively executed and is a major plus. Its broad and deep intellectual property (IP) portfolio, with patent coverage across vital enabling technologies also positions the company as a leader in innovation.\n(You can read the full research report on Enzo here >>>)\nWhy Haven't You Looked at Zacks' Top Stocks?\nSince 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.\nToday you can access their live picks without cost or obligation.\nSee Stocks Free >>\nMedia Contact\nZacks Investment Research\n800-767-3771 ext. 9339\nsupport@zacks.com\nhttps://www.zacks.com\nPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nAmgen Inc. (AMGN) : Free Stock Analysis Report\nEaton Corporation, PLC (ETN) : Free Stock Analysis Report\nEnzo Biochem, Inc. (ENZ) : Free Stock Analysis Report\nSony Corporation (SONY) : Free Stock Analysis Report\nMoving iMage Technologies, Inc. (MITQ): Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2489323874"}